{"id":"NCT00599326","sponsor":"University of Texas Southwestern Medical Center","briefTitle":"Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda","officialTitle":"Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-01","primaryCompletion":"2010-04","completion":"2010-04","firstPosted":"2008-01-23","resultsPosted":"2014-02-10","lastUpdate":"2014-02-10"},"enrollment":10,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Porphyria Cutanea Tarda"],"interventions":[{"type":"DRUG","name":"Deferasirox","otherNames":["Exjade"]}],"arms":[{"label":"A","type":"EXPERIMENTAL"}],"summary":"To determine the efficacy and tolerability of deferasirox in the treatment of Porphyria Cutanea Tarda.\n\nPrimary objective - the elimination of all blistering within 6 months of treatment.\n\nSecondary objective - decrease in total body iron levels.","primaryOutcome":{"measure":"Number of Participants Showing Reduction or Elimination of Skin Blistering","timeFrame":"Within 6 months of treatment.","effectByArm":[{"arm":"Deferasirox","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":8},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["22911183"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":10},"commonTop":["Abdominal pain (Mild)"]}}